Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01332032 · ClinicalTrials.gov registry record
Promoting Breast Cancer Screening in Non-adherent Women
A clinical trial of Breast Cancer, sponsored by University of Massachusetts, Worcester.
- Completed
- Registry status
- 36,348
- Enrollment target
- 1
- Study location
NCT01332032: Completed study of Breast Cancer, sponsored by University of Massachusetts, Worcester.
NCT01332032 is a study of Breast Cancer that has completed, run by University of Massachusetts, Worcester. The registered enrollment target is 36,348 participants, above the 2,774-participant average among 1,224 other Breast Cancer trials with a reported enrollment target (1210% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01332032, a study of Breast Cancer, has completed, sponsored by University of Massachusetts, Worcester.
- COMPLETED
- Registry status
- 36,348 participants
- Enrollment target
- 1
- Study location
Study Summary
This randomized study compares the effectiveness and cost-effectiveness of 3 proven methods of reaching out to women who are coming due for or who are overdue for a mammogram. The study originally embedded in a community healthcare plan and an associated community clinic, now accepts patients using the community clinic and 3 other health care plans. The study makes use of a complex computer driven reminder system. The study also will examine ways to improve the efficiency and sequencing of the interventions by identifying patient factors associated with intervention effectiveness.
Primary Outcome
The outcome will be determined for each of the 4 years of intervention. But the main interest will be the outcome measured in the final intervention year because we believe this best illustrates the magnitude of intervention effect that could be achieved in future years.
Conditions Studied
Interventions
- BEHAVIORAL Reminder Letter
- BEHAVIORAL Reminder Call
- BEHAVIORAL Counselor Call
Study Locations (1)
Massachusetts
- Reliant Medical Group - Worcester
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 36,348 participants |
| Start Date | 2009-07 |
| Est. Completion | 2015-05 |
What the finished NCT01332032 record still lists
NCT01332032 is an observational study that tracks outcomes without assigning an intervention. Its 36,348 participants enrollment target places it among the larger protocols in the corpus, above the 2,774-participant average among 1,224 other Breast Cancer trials with a reported enrollment target (1210% higher).
The record links to 1 condition, with Breast Cancer appearing as the primary indexed condition, and to 3 interventions - of which Reminder Letter is the first listed.
NCT01332032 reports a single indexed study location in Massachusetts.
Frequently Asked Questions
What is clinical trial NCT01332032 about?
NCT01332032 is a clinical study titled "Promoting Breast Cancer Screening in Non-adherent Women". This randomized study compares the effectiveness and cost-effectiveness of 3 proven methods of reaching out to women who are coming due for or who are overdue for a mammogram. The study originally embedded in a community healthcare plan and an associated community clinic, now accepts patients using ...
What is the current status of trial NCT01332032?
This trial is currently completed. The enrollment target is 36,348 participants. The study started on 2009-07. Estimated completion is 2015-05.
What conditions does trial NCT01332032 study?
This clinical trial studies the following conditions: Breast Cancer.
What interventions are being tested in trial NCT01332032?
The interventions under investigation include: Reminder Letter (BEHAVIORAL), Reminder Call (BEHAVIORAL), Counselor Call (BEHAVIORAL).
Who is sponsoring clinical trial NCT01332032?
This trial is sponsored by University of Massachusetts, Worcester, which has 240 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01332032 being conducted?
This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Breast Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT01332032's enrollment target sits among peer trials
36,348 5th of 1224 higher than 1,220 of 1,224 other Breast Cancer trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Breast Cancer trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Collection of Blood From Patients With Cancer, Other Tumors, or Tumor Predisposition Syndromes for Genetic Analysis
RECRUITING
-
Surviving Daily Life
RECRUITING
-
Real World Treatment Experience of Patients With Breast, Lung, Ovarian, Multiple Myeloma, or Acute Myelogenous Leukemia Using Remote Symptom Monitoring
RECRUITING
-
UNC Pleural Fluid Registry
RECRUITING
-
Harnessing Analysis RNA Expression and Molecular Subtype to Optimize Novel TherapY MBCA
RECRUITING · NA
-
Post-operative Radiotherapy Omission in Selected Patients With Early Breast Cancer Trial International VErsion (PROSPECTIVE)
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT07150923 · 36,503 participants · NA
Supraglottic Airway for Resuscitation Trial
- NCT03262259 · 36,000 participants · NA
Evaluation of Global Smart Drinking Goals Initiative
- NCT05796505 · 37,122 participants · NA
Addressing Vaccine Acceptance in Carceral Settings Through Community Engagement
- NCT02225301 · 35,000 participants · NA
iLookOut for Child Abuse -Online Learning Module for Early Childcare Providers
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia